• Chromosome Analysis, Solid Tumors
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • MLYCD Gene Mutation Analysis, Blood
  • Immunoglobulins (IgG, IgA, IgM)
  • Idiopathic Pulmonary Fibrosis Diagnostic Test (Envisia™)
  • Lidocaine, Serum
  • Alpha 1 Microglobulin, 24 Hour, Urine
  • Primary Hyperoxaluria Gene Mutation Panel
  • 11-Deoxycortisol, Quantitative, Serum
  • Glutamic Acid Decarboxylase (GAD65) Antibody, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
Medical Test

Clinical Utility
Access to Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq) is restricted.